Skip header and navigation

Refine By

9 records – page 1 of 1.

Children with atopic histories exhibit impaired lipopolysaccharide-induced Toll-like receptor-4 signalling in peripheral monocytes.

https://arctichealth.org/en/permalink/ahliterature142106
Source
Clin Exp Allergy. 2010 Nov;40(11):1648-57
Publication Type
Article
Date
Nov-2010
Author
D. Préfontaine
A-A Banville-Langelier
P-O Fiset
J. Guay
J. An
M. Mazer
Q. Hamid
B D Mazer
Author Affiliation
Meakins Christie Laboratories and Montreal Children's Hospital Research Institute, McGill University Health Center Research Institute, Montreal, QC, Canada.
Source
Clin Exp Allergy. 2010 Nov;40(11):1648-57
Date
Nov-2010
Language
English
Publication Type
Article
Keywords
Adolescent
Adult
Antigens, CD14 - metabolism
Antigens, CD3 - metabolism
Antigens, CD4 - metabolism
Case-Control Studies
Child
Child, Preschool
Extracellular Signal-Regulated MAP Kinases - metabolism
Flow Cytometry
Humans
Hypersensitivity - immunology
Immunity, Innate - drug effects
Interleukin-4 - metabolism
Lipopolysaccharides - pharmacology
Middle Aged
Monocytes - drug effects - immunology
Phosphorylation
Quebec
Signal Transduction - drug effects
Toll-Like Receptor 4 - agonists - metabolism
Young Adult
p38 Mitogen-Activated Protein Kinases - metabolism
Abstract
The hygiene hypothesis states that early exposure to bacterial products such as lipopolysaccharide (LPS) may be protective against the development of allergic diseases. Whether atopic disease affects the ability of immune cells to respond to LPS is unclear. Our laboratory has demonstrated previously that children express high levels of Toll-like receptor (TLR)-4 on CD4(+) cells in nasal mucosa.
To determine if children with a history of allergic disease have impaired responses to LPS on circulating CD4(+) leucocytes.
Peripheral blood mononuclear cells from children (aged 2-18) and adults with or without a history of atopic conditions were cultured with/without IL-4 or LPS for up to 24 h. Expression of surface TLR-4, CD14, CD4, CD3, as well as of intracellular phosphorylated (p42/p44) ERK and p38 mitogen-activated protein kinase (MAPK) were assessed by flow cytometry.
A history of atopy in children was associated with impaired LPS-induced TLR-4-dependent phosphorylation of (p42/44) ERK and p38 MAPK by CD4(+) monocytes. Decreased LPS signalling was reproduced by pre-incubation of control cells with recombinant IL-4. LPS stimulation also decreased TLR-4 expression on monocytes from children without atopic histories but not from atopic subjects. CD4(+) T lymphocytes showed limited LPS responsiveness, regardless of atopic status. In contrast with non-atopic children, TLR-4 expression on monocytes of children with atopic histories decreased as a function of age.
This study provides evidence for defective LPS recognition on circulating CD4(+) leucocytes of subjects with atopic histories compared with those from non-atopic children. CD4(+) TLR4(+) monocytes from children with atopic histories failed to phosphorylate MAPKs. Our results suggest that a history of atopic disease is associated with impaired TLR-4-mediated innate immune function compared with non-atopic children.
PubMed ID
20636402 View in PubMed
Less detail

[Immune reactivity indices of workers in the manufacture of viscose].

https://arctichealth.org/en/permalink/ahliterature239649
Source
Ter Arkh. 1985;57(1):109-11
Publication Type
Article
Date
1985
Author
N L Popova
E A Ivanov
M I Kozlovtsev
Iu D Goncharenko
Source
Ter Arkh. 1985;57(1):109-11
Date
1985
Language
Russian
Publication Type
Article
Keywords
Adolescent
Adult
B-Lymphocytes - drug effects - immunology
Blood Donors
Cellulose
Environmental Exposure
Female
Humans
Immunity, Innate - drug effects
Immunoglobulins - analysis
Lymphocyte Activation - drug effects
Male
Middle Aged
Rosette Formation
Russia
T-Lymphocytes - drug effects - immunology
Textile Industry
Abstract
A total of 300 workers engaged in viscose industry were examined for leukocyte blast transformation, spontaneous and complement rosette-formation, blood serum immunoglobulins, bactericidal activity of blood serum, lysozyme titre, phagocytic activity of neutrophils, and the NBT test. The data obtained attest to the changes in the total nonspecific body responsiveness of the workers examined. The character and degree of the changes in cellular and humoral immunity were marked by cycles, depending on the workers' record. The changes in the total nonspecific responsiveness were found to persist for a long time even after discontinuation of the contact with carbon disulfide.
PubMed ID
3157228 View in PubMed
Less detail

[Immunomodulation characteristics of Lactobacillus genus bacteria]

https://arctichealth.org/en/permalink/ahliterature98708
Source
Mikrobiol Z. 2009 May-Jun;71(3):41-7
Publication Type
Article
Author
S O Starovoitova
N O Tymoshok
V Iu Horchakov
M Ia Spivak
Source
Mikrobiol Z. 2009 May-Jun;71(3):41-7
Language
Ukrainian
Publication Type
Article
Keywords
Animals
Cell Line
Fibroblasts - drug effects - immunology
Immunity, Innate - drug effects
Immunologic Factors - pharmacology
Interferon-alpha - blood
Killer Cells, Natural - immunology
Lactobacillus - physiology
Macrophages, Peritoneal - drug effects - immunology
Mice
Phagocytosis - drug effects - immunology
Probiotics - pharmacology
Spleen - cytology - drug effects - immunology
Tumor Necrosis Factor-alpha - blood
Abstract
Immunomodulation properties of the composition which contains live cells of bacteria of genus Lactobacillus: L. delbrueckii subsp. bulgaricus LB86 VKPM B-5788, L. delbrueckii subsp. delbrueckii DSM20074, L. rhmanosus LB3 IMB B-7038, L. acidophilus, L. rhamnosus VR were studied. Stimulation of phagocytic system under the influence of lactobacteria composition correlated with an increase of cytotoxic activity of natural killer cells and with their influence on synthesis of cytokines: interferon and tumor necrosis factor was shown.
PubMed ID
19938605 View in PubMed
Less detail

Lipooligosaccharide Structures of Invasive and Carrier Isolates of Neisseria meningitidis Are Correlated with Pathogenicity and Carriage.

https://arctichealth.org/en/permalink/ahliterature274250
Source
J Biol Chem. 2016 Feb 12;291(7):3224-38
Publication Type
Article
Date
Feb-12-2016
Author
Constance M John
Nancy J Phillips
Richard Din
Mingfeng Liu
Einar Rosenqvist
E Arne Høiby
Daniel C Stein
Gary A Jarvis
Source
J Biol Chem. 2016 Feb 12;291(7):3224-38
Date
Feb-12-2016
Language
English
Publication Type
Article
Keywords
Acylation
Adolescent
Antigens, Bacterial - biosynthesis - chemistry - toxicity
Carrier State - blood - cerebrospinal fluid - immunology - microbiology
Cell Line, Tumor
Computational Biology
Gene Expression Profiling
Humans
Immunity, Innate - drug effects
Lipopolysaccharides - biosynthesis - chemistry - toxicity
Meningitis, Meningococcal - blood - cerebrospinal fluid - immunology - microbiology
Meningococcal Infections - blood - cerebrospinal fluid - immunology - microbiology
Molecular Structure
Monocytes - drug effects - immunology - metabolism
Neisseria meningitidis, Serogroup B - classification - immunology - metabolism - pathogenicity
Neisseria meningitidis, Serogroup C - classification - immunology - metabolism - pathogenicity
Norway
Phosphorylation
Sepsis - blood - cerebrospinal fluid - immunology - microbiology
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
Tumor Necrosis Factor-alpha - metabolism
Virulence
Abstract
The degree of phosphorylation and phosphoethanolaminylation of lipid A on neisserial lipooligosaccharide (LOS), a major cell-surface antigen, can be correlated with inflammatory potential and the ability to induce immune tolerance in vitro. On the oligosaccharide of the LOS, the presence of phosphoethanolamine and sialic acid substituents can be correlated with in vitro serum resistance. In this study, we analyzed the structure of the LOS from 40 invasive isolates and 25 isolates from carriers of Neisseria meningitidis without disease. Invasive strains were classified as groups 1-3 that caused meningitis, septicemia without meningitis, and septicemia with meningitis, respectively. Intact LOS was analyzed by high resolution matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Prominent peaks for lipid A fragment ions with three phosphates and one phosphoethanolamine were detected in all LOS analyzed. LOS from groups 2 and 3 had less abundant ions for highly phosphorylated lipid A forms and induced less TNF-a in THP-1 monocytic cells compared with LOS from group 1. Lipid A from all invasive strains was hexaacylated, whereas lipid A of 6/25 carrier strains was pentaacylated. There were fewer O-acetyl groups and more phosphoethanolamine and sialic acid substitutions on the oligosaccharide from invasive compared with carrier isolates. Bioinformatic and genomic analysis of LOS biosynthetic genes indicated significant skewing to specific alleles, dependent on the disease outcome. Our results suggest that variable LOS structures have multifaceted effects on homeostatic innate immune responses that have critical impact on the pathophysiology of meningococcal infections.
Notes
Cites: J Biol Chem. 1990 Sep 25;265(27):16444-92398058
Cites: Infect Immun. 1991 Jun;59(6):1881-71903767
Cites: J Immunol. 1991 Jul 1;147(1):298-3051711080
Cites: Lancet. 1991 Nov 2;338(8775):1093-61682541
Cites: Mol Immunol. 1991 Nov;28(11):1233-421720505
Cites: J Bacteriol. 1992 Mar;174(6):1793-8001548229
Cites: Crit Rev Microbiol. 1998;24(4):281-3349887366
Cites: J Infect. 1999 Jul;39(1):42-810468128
Cites: Glycobiology. 2005 Apr;15(4):409-1915574803
Cites: Nat Immunol. 2005 Oct;6(10):989-9416155573
Cites: Infect Immun. 2005 Nov;73(11):7390-716239538
Cites: J Biol Chem. 2006 Jul 21;281(29):19939-4816687398
Cites: NIPH Ann. 1991 Dec;14(2):107-21; discussion 121-31812424
Cites: NIPH Ann. 1991 Dec;14(2):139-43; discussion 144-61812428
Cites: J Clin Microbiol. 1992 Aug;30(8):2047-531380009
Cites: J Infect Dis. 1992 Nov;166(5):1079-881402019
Cites: Infect Immun. 1994 May;62(5):1566-757513302
Cites: Infect Immun. 1994 May;62(5):1755-608168937
Cites: Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):12742-718753624
Cites: Infect Immun. 2008 Dec;76(12):5777-8918824535
Cites: J Biol Chem. 2009 Jan 2;284(1):6-1618986988
Cites: J Biol Chem. 2009 Feb 13;284(7):4616-2519095648
Cites: Infect Immun. 2009 Mar;77(3):1112-2019114544
Cites: J Lipid Res. 2009 Mar;50(3):424-3818832773
Cites: Clin Microbiol Rev. 2000 Jan;13(1):144-66, table of contents10627495
Cites: J Bacteriol. 1996 Mar;178(5):1265-738631701
Cites: Med Microbiol Immunol. 1996 Sep;185(2):81-78884739
Cites: Infect Immun. 1997 Nov;65(11):4436-449353017
Cites: Glycobiology. 1998 Apr;8(4):359-659499383
Cites: Eur J Biochem. 1998 Jun 15;254(3):626-339688275
Cites: J Med Microbiol. 1998 Nov;47(11):993-89822298
Cites: Infect Immun. 1998 Dec;66(12):5939-479826376
Cites: PLoS Pathog. 2006 Jun;2(6):e6716846256
Cites: Crit Care Med. 2006 Aug;34(8):2182-716775571
Cites: Infect Immun. 2007 Feb;75(2):1025-3317101655
Cites: J Biol Chem. 2007 Mar 16;282(11):7877-8417227775
Cites: J Biol Chem. 2007 May 4;282(18):13726-3517322564
Cites: Lancet. 2007 Jun 30;369(9580):2196-21017604802
Cites: PLoS Pathog. 2009 Apr;5(4):e100039619390612
Cites: J Biol Chem. 2009 Aug 7;284(32):21515-2519531474
Cites: Carbohydr Res. 2008 Nov 24;343(17):2971-918804756
Cites: Infect Immun. 2010 Feb;78(2):802-919933829
Cites: J Immunol. 2010 Dec 1;185(11):6974-8421037101
Cites: BMC Bioinformatics. 2010;11:59521143983
Cites: J Infect. 2011 Jun;62(6):479-8321459106
Cites: J Immunol. 2011 Sep 15;187(6):3314-2021849675
Cites: Methods Mol Biol. 2012;799:21-3521993637
Cites: PLoS One. 2011;6(10):e2613022028815
Cites: J Biol Chem. 2011 Dec 23;286(51):43622-3322027827
Cites: Emerg Infect Dis. 2012 Jan;18(1):63-7022261040
Cites: Infect Immun. 2012 Feb;80(2):643-5022104107
Cites: J Leukoc Biol. 2012 May;91(5):721-722389313
Cites: J Immunol. 2012 May 15;188(10):5063-7222504643
Cites: Crit Care. 2012;16(1):R1422269279
Cites: Infect Immun. 2012 Nov;80(11):4014-2622949553
Cites: PLoS One. 2012;7(11):e4929523209568
Cites: Infect Immun. 2013 Jan;81(1):33-4223071134
Cites: Emerg Infect Dis. 2013 Apr;19(4):566-7323628376
Cites: J Biol Chem. 2013 Jul 5;288(27):19661-7223629657
Cites: Mol Microbiol. 2013 Aug;89(3):433-4923750848
Cites: MBio. 2013;4(6):e00892-1324255126
Cites: J Immunol. 2014 Feb 15;192(4):1768-7724442429
Cites: J Infect. 2014 May;68(5):455-6124393652
Cites: Lancet. 2014 Nov 22;384(9957):190025457917
Cites: APMIS. 2000 Feb;108(2):107-1210737455
Cites: Infect Immun. 2001 Oct;69(10):5981-9011553534
Cites: Infect Immun. 2002 Jan;70(1):407-1111748209
Cites: Eur J Biochem. 2002 Sep;269(17):4169-7512199694
Cites: Clin Biochem. 2002 Sep;35(6):455-6112413606
Cites: Prev Med. 2003 Apr;36(4):502-912649059
Cites: J Pharmacol Exp Ther. 2003 Nov;307(2):737-4412970380
Cites: J Biol Chem. 2003 Dec 19;278(51):50853-6214525973
Cites: J Med Microbiol. 2004 Sep;53(Pt 9):821-3215314188
Cites: J Clin Pathol. 1983 Feb;36(2):213-236338050
Cites: Infect Immun. 1987 Jul;55(7):1652-62439458
Cites: J Infect Dis. 1987 Jul;156(1):107-123110302
PubMed ID
26655715 View in PubMed
Less detail

[The effect of etimizol on the functional status of the blood coagulation systems and fibrinolysis in workers on expedition-duty watches working under the climatic conditions of northern Tyumen Province].

https://arctichealth.org/en/permalink/ahliterature215241
Source
Eksp Klin Farmakol. 1995 May-Jun;58(3):40-2
Publication Type
Article
Author
S I Bogoslovskaia
G P Gladilin
Source
Eksp Klin Farmakol. 1995 May-Jun;58(3):40-2
Language
Russian
Publication Type
Article
Keywords
Adaptation, Physiological - drug effects
Adult
Blood Coagulation - drug effects
Cold Climate
Etimizol - administration & dosage - pharmacology
Fibrinolysis - drug effects
Humans
Immunity, Innate - drug effects
Lipid Peroxidation - drug effects
Male
Petroleum
Siberia
Time Factors
Abstract
The study was undertaken to reveal the effects of ethymisole on the functional status of blood coagulation and fibrinolytic systems, the body's adaptative reserves of workers from expeditionary-duty teams. Ethymisole was found to normalize the functional status of blood coagulation and fibrinolytic systems, to restore conjunction of their functioning. The use of the drug was ascertained to normalize the activity of lipid peroxidation products, to enhance the adaptative reserves of expeditionary-duty workers by prolonging the resistance phase. It is concluded that ethymisole may be used as an agent that enhances the body's adaptative reserves.
PubMed ID
7663295 View in PubMed
Less detail

[The organizational epidemiological problems of performing mass antigen-nonspecific immunoprophylactic measures].

https://arctichealth.org/en/permalink/ahliterature217005
Source
Zh Mikrobiol Epidemiol Immunobiol. 1994 Nov-Dec;(6):52-3
Publication Type
Article

[The theoretical and practical aspects of the nonspecific prevention of infectious diseases among the troops].

https://arctichealth.org/en/permalink/ahliterature211310
Source
Voen Med Zh. 1996 Aug;317(8):40-3, 80
Publication Type
Article
Date
Aug-1996
Author
T A Semenenko
V S Perepelkin
S V Prozorovskii
Source
Voen Med Zh. 1996 Aug;317(8):40-3, 80
Date
Aug-1996
Language
Russian
Publication Type
Article
Keywords
Adjuvants, Immunologic - therapeutic use
Communicable Disease Control - methods
Humans
Immunity, Innate - drug effects
Military Personnel
Russia
Seasons
Abstract
As possible alternative to a complex of sanitary-hygienic measures, directed on the infectious diseases prevention, not specific prophylaxis with the aid of immunomodulative preparations is offered. Prospects of the immunomodulative preparations application is defined by transition to popularized epidemiological thinking planned in modern conditions. Strategy of total and selective not specific prophylaxis, results of own researches on estimation of preventive efficiency of dibazolum and prodigiosanum during acute respiratory disease and virus hepatitis A are described.
PubMed ID
9036646 View in PubMed
Less detail

9 records – page 1 of 1.